Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ahmed, IN
Kamal Ahmed, Hydergabad IN
| Patent application number | Description | Published |
|---|---|---|
| 20090036657 | PYRROLO[2, 1-C][1, 4]BENZODIAZEPINE-GLYCOSIDE PRODRUG USEFUL AS A SELECTIVE ANTI TUMOR AGENT - The present invention provides novel pyrrolo[2,1-c][1,4]benzodiazepine-glycoside prodrug of general formula 1a-b, useful as selective anticancer agents. The present invention also provides a process for the preparation of novel pyrrolo[2,1-c][1,4]benzodiazepine-glycoside prodrugs of general formula 1a-b. This invention also provides activation of these produgs by | 02-05-2009 |
Kamal Ahmed, Andra Pradesh IN
| Patent application number | Description | Published |
|---|---|---|
| 20110213165 | NOVEL 4BETA-AMINO PODOPHYLLOTOXIN CONGENERS AS ANTI TUMOUR ANTIBIOTICS A PROCESS FOR THE PREPARATION THEREOF - The present invention provides novel β-amino podophyllotoxin congeners of general formula (A); R═CH | 09-01-2011 |
Kamal Ahmed, Andhra Pradesh IN
| Patent application number | Description | Published |
|---|---|---|
| 20110166346 | NOVEL NAPTHALIMIDE-BENZIMIDAZOLE HYBRIDS AS POTENTIAL ANTITUMOR AGENTS AND PROCESS FOR THE PREPARATION THEREOF - The present invention provides the compounds of general formula 5 and 9 useful as potential antitumour agents against human cancer cell lines. The present invention further provides the process for preparation of napthalimide-benzimidazole hybrids of general formula 5 and 9, n-1-2, R=n-methylpiperazine or morpholine (Formula 9), wherein: n=2-3, m=2-3 and R=n-methylpiperazine or morpholine. | 07-07-2011 |
Kamal Ahmed, Hyderabad IN
| Patent application number | Description | Published |
|---|---|---|
| 20080275248 | NOVEL 4BETA-AMINO PODOPHYLLOTOXIN CONGENERS AS POTENTIAL ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION THEREOF - The present invention provides new class of 4β-[4″-(1″,3″-benzothiazole-2″-yl)anilino]podophyllotoxin analogues having the structural formula as follows (4). | 11-06-2008 |
| 20110118237 | Isoxazoline linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and the process for preparation thereof - The present invention provides compounds of general formula (5a-d) and (9a-h) useful as potential antitumour agents against human cancer cell lines. The present invention also provides a process for the preparation of pyrrolo [2,1-c][1,4]benzodiazepine hybrids of general formula (5a-d) and (9a-h). | 05-19-2011 |
| 20110207924 | NEW PHENANTHRYLPHENOL LINKED PYRROLO [2, L-C] [L, 4] BENZODIAZEPINE HYBRIDS AS POTENTIAL ANTITUMOUR AGENTS AND PROCESS FOR THE PREPARATION THEREOF - The present invention provides a compounds of general formula (6), useful as potential antitumour agents against human cancer cell lines. The present invention further provides a process for the preparation of pyrrolo[2,1-c][1,4]benzodiazepine hybrids of general formula (6). | 08-25-2011 |
| 20120095213 | CINNAMIDO-PYRROLO[2,1-C][1,4]BENZODIAZEPINES AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF - The present invention provides a compound of general formulae (8a-i), (11a-i), (14a-i), and (17a-i), useful as potential antitumour agents against human cancer cell lines. The present invention further provides a process for the preparation of Cinnamido-pyrrolo[2,1-c][1,4]benzodiazepines of general formulae (8a-i), (11a-i), (14a-i), and (17a-i). | 04-19-2012 |
| 20120095214 | QUINAZOLINONE LINKED PYRROLO[2,1-C][1,4]BENZODIAZEPINE HYBRIDS AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF - The present invention provides a compound of general formulae 5a-r, 9a-i to 13a-i and 17a-i to 22a-i, useful as potential antitumour agents against human cancer cell lines. The present invention further provides a process for the preparation of pyrrolo[2,1-c][1,4]benzodiazepine hybrids of general formulae 5a-r, 9a-i to 13a-i and 17a-i to 22a-i. | 04-19-2012 |
| 20120101270 | NOVEL PYRROLO[2,1-C][1,4] BENZODIAZEPINE DERIVATIVES WITH DITHIOCARBAMATE SIDE CHAINS AND PROCESS FOR THE PREPARATION THEREOF - The present invention provides synthesis and in vitro anticancer activity of novel pyrrolo[2,1-c][1,4]benzodiazepine derivatives with dithiocarbamate side chains. The present invention also relates to a process for the preparation of new pyrrolo[2,1-c][1,4]benzodiazepine derivatives with dithiocarbamate side chains of general formula (A) and a process for the preparation thereof. | 04-26-2012 |
Monsur Borbhuiya Ahmed, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20090035815 | Synthetic Gene for Enhanced Expression in E. Coli - A novel nesiritide synthetic cDNA chimera encoding human b-type natriuretic peptide (hBNP) or nesiritide and a process for the preparation of the said novel chimera. Further, the inventors disclose the use of nesiritide synthetic cDNA chimera to obtain an expressible construct to produce mature nesiritide. Particularly, the inventors disclose an application of recombinant cloning method to prepare an ORF of a nesiritide chimeric construct, which is simultaneously codon optimized for | 02-05-2009 |
Sayed Murtuza Ahmed, Amravati IN
| Patent application number | Description | Published |
|---|---|---|
| 20090285675 | Systems and Methods for Modifying Modal Vibration Associated with a Turbine - Shroud assemblies and methods for modifying modal vibrations associated with a turbine are described. A shroud assembly includes an inner shroud and an outer shroud. The inner shroud includes a body with a first end portion, a second end portion opposite to the first end portion, an upper surface and a lower surface, wherein the lower surface is adjacent to a plurality of rotating turbine blades. The inner shroud further includes at least two rails formed on the upper surface and extending between the first end portion and the second end portion, wherein an impingement cooling area is defined between the at least two rails. Additionally, the inner shroud includes at least one cross-member formed on the upper surface in a direction transverse to the at least two rails. | 11-19-2009 |
Shahadal Ahmed, Haryana IN
| Patent application number | Description | Published |
|---|---|---|
| 20100286211 | OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS - The present invention relates to certain substituted phenyl oxazolidinones and to processes for the synthesis of the same. This invention also relates to pharmaceutical compositions containing the compounds of the present invention as antimicrobials. The compounds are useful antimicrobial agents, effective against a number of human and veterinary pathogens, including gram-positive aerobic bacteria, for example, multiple-resistant | 11-11-2010 |
Shahadat Ahmed, Gurgaon IN
| Patent application number | Description | Published |
|---|---|---|
| 20080300251 | Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors - The present invention relates to novel 3-azabicyclo[3.1.0]hexane derivatives as dipeptidyl peptidase-IV inhibitors and the processes for the synthesis of the said compounds. This invention also relates to pharmacological compositions containing the compounds of the present invention, and methods of treating diabetes, especially type 2 diabetes, as well as prediabetes, diabetic dyslipidemia, metabolic acidosis, ketosis, satiety disorders, and obesity. These inhibitors can also be used to treat conditions manifested by a variety of metabolic, neurological, anti-inflammatory, and autoimmune disorders like inflammatory disease, multiple sclerosis, rheumatoid arthritis; viral, cancer and gastrointestinal disorders. The compounds of this invention can also be used for treatment of infertility arising due to polycystic ovary syndrome. | 12-04-2008 |
| 20090156465 | DERIVATIVES OF BETA-AMINO ACID AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS - The present invention relates to β-amino acid derivatives as dipeptidyl peptidase-IV inhibitors and the processes for the synthesis of the same. This invention also relates to pharmacological compositions containing the compounds of the present invention, and methods of treating diabetes, especially type 2 diabetes, as well as prediabetes, diabetic dyslipidemia, metabolic acidosis, ketosis, satiety disorders, and obesity. These inhibitors can also be used to treat conditions manifested by a variety of metabolic, neurological, anti-inflammatory, and autoimmune disorders like inflammatory disease, multiple sclerosis, rheumatoid arthritis; viral, cancer and gastrointestinal disorders. The compounds of this invention can also be used for treatment of infertility arising due to polycystic ovary syndrome. | 06-18-2009 |
Shahadat Ahmed, Haryana IN
| Patent application number | Description | Published |
|---|---|---|
| 20090215764 | Antimicrobial agents - Provided herein are substituted aromatic compounds, which are tRNA synthetase inhibitors, and hence can be used as antimicrobial agents. Compounds described herein can be used for the treatment or prevention of a condition caused by or contributed to by gram positive, gram negative, anaerobic bacteria or fungal organisms, more particularly against bacterium, for example, | 08-27-2009 |
Shahadat Ahmed, Karimganj IN
| Patent application number | Description | Published |
|---|---|---|
| 20120108565 | PYRROLE CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS - The present invention provides DNA Gyrase and/or Topo IV inhibitors of Formula (I), which can be used as antibacterial agents. Compounds disclosed herein can be used for treating or preventing conditions caused by or contributed by gram positive, gram negative and anaerobic bacteria, more particularly against, for example, | 05-03-2012 |
Shubbir Ahmed, Hewrah IN
| Patent application number | Description | Published |
|---|---|---|
| 20080300843 | RECOMBINANT MESO-ACTIVE THERMOSTABLE PROTEINS AND PROCESSES OF DESIGN AND BIOSYNTHESIS THEREOF - The present invention deals with examination of the alterability of part, or whole, of the surfaces of beta sheet-based protein structures, focusing especially on enzymes. The alteration is done by supplanting/transplanting a part, or whole, of the surface of one protein onto the surface of a homologous protein of superimposable polypeptide backbone, by exploiting the structural features of beta sheets to alter only the regions of the surface involved in substrate/ligand binding and catalysis. The transplantation involves replacement of a selected set of non-contiguous residues constituting the surface regions desired to be altered in one enzyme/protein, by a set of non-contiguous residues located at analogous positions in the other enzyme/protein, in a manner that is likely to facilitate folding and function of the new protein formed by combining residues from both enzymes/proteins. The present invention also deals with using this surface engineering approach to selectively combine enzyme/protein characteristics from different domains of life that are not ordinarily combined by natural evolution, such as the creation of novel proteins that retains the bulk of the thermostable scaffold of a thermophile enzyme onto which the active surface of a mesophile homolog is transplanted, so as to create a thermo-stable protein with meso-active functional characteristics of pH and temperature of optimal function. | 12-04-2008 |
Zakir Ahmed, Kamataka IN
| Patent application number | Description | Published |
|---|---|---|
| 20100110469 | METHOD FOR PRINTING ON AN IMAGING DEVICE - A method for printing a print ready file transmitted by a print client on an imaging device includes creating a print data file associated with the print ready file, where the print data file includes information pertaining to the print ready file and the imaging device. In the method, the print data file is encrypted and transmitted to the imaging device. In addition, the print data file is authenticated in the imaging device and printing of the print ready file is enabled if the print data file is determined to be authentic and the print ready file is invalidated if the print data file is determined to be inauthentic. Also disclosed is an imaging device configured to perform the aforementioned method. | 05-06-2010 |